Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ
Status:
Not yet recruiting
Trial end date:
2023-08-25
Target enrollment:
Participant gender:
Summary
This study aims to investigate the safety and efficacy of radiotherapy combined with
Toripalimab (PD-1 inhibitor) in the treatment of locally advanced adenocarcinoma of the
gastroesophageal junction.